Reports

Industry Research Reports

Global Sirolimus API Market Research Report 2026

Global Sirolimus API Market Research Report 2026

Industry: Chemical & Material

Published Date: 2026-08-23

Pages: 143 Pages

Report ld: 6502876

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

Sirolimus API Market Size(US$)

den_QYR1
cagr

CAGR 2026-2032

6.4%

marketSize

Market Size,2032

USD 372

Million

Market Snapshot

Market Size in 2026 (Value)
US$ 256 million
Market Forecast in 2032(Value)
US$ 372 million
CAGR
6.4%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Sirolimus API market was valued at US$ 236 million in 2025 and is anticipated to reach US$ 372 million by 2032, at a CAGR of 6.4% from 2026 to 2032.

Sirolimus API is a macrolide fermentation-based active pharmaceutical ingredient, industrially obtained primarily through fermentation with Streptomyces hygroscopicus, followed by extraction, separation, purification, crystallization, and refining to form an API that meets pharmaceutical quality standards. Sirolimus exerts immunosuppressive and antiproliferative effects by binding to FKBP12 and inhibiting the mTOR pathway. Its traditional core application is in the preparation of anti-rejection drugs for kidney transplantation, but its applications have expanded to areas such as lymphangioleiomyomatosis (LAM), tuberous sclerosis-related facial angiofibroma, treatment of certain tumors, and sirolimus-eluting coronary stents.

The future market will continue to be driven by stable demand for immunosuppressive therapy in organ transplantation, but growth will mature. Sirolimus is already a relatively mature mTOR inhibitor and faces competition from other immunosuppressive therapies such as Tacrolimus, Cyclosporine, Mycophenolate, and Everolimus. Therefore, the traditional transplant market is unlikely to experience explosive growth. However, the increase in global transplant surgeries, long-term immunosuppressive therapy, and the penetration of generic drugs in emerging markets will maintain stable API demand.

The demand structure for sirolimus is expanding from traditional oral immunosuppressants to "multiple dosage forms + multiple indications." In addition to traditional tablets and oral solutions, the FDA has approved sirolimus topical gel for tuberous sclerosis-related facial angiofibroma; nab-sirolimus has entered the field of oncology treatment such as PEComa. For API suppliers, the significance of this change is not simply increasing the kilograms, but rather the differentiated requirements for purity, particle size, impurities, stability, and customer quality agreements imposed by different dosage forms, further enhancing the added value of high-specification API products. Drug elution devices are a very distinctive application of Sirolimus API, and their growth rate may be higher than that of traditional transplant drugs. Sirolimus has a strong anti-proliferative effect and can be used as an active ingredient in the coating of coronary drug-eluting stents to reduce the risk of restenosis.

MARKET SEGMENTATION

By Company

  • Concord Biotech
  • Curia Italy
  • Lonza Biologics Tuas Pte Ltd
  • Apotex Pharmachem
  • Chunghwa Chemical Synthesis & Biotech
  • Hisun Pharmaceutical
  • Fujian Kerui Pharmaceutical
  • Lunan New Time Bio Tech
  • BrightGene Bio-Medical Technology
  • Hangzhou Zhongmei Huadong Pharmaceutical
  • Chongqing Daxin Pharmaceutical
  • North China Pharmaceutical Huasheng
  • Zhejiang Wild Wind Pharmaceutical
  • Yangzhou Lianao Biopharmaceutical

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • 98%-99%
  • Above 99%

Segment by Application

  • Tablets
  • Oral Solution
  • Gel
  • Others

Segment by Category

  • Pharmaceutical Grade
  • Cosmetic Grade

Segment by Division

  • Pharmaceutical Companies
  • Medical Device Manufacturers
  • CDMO/Research Institutions

biaoTi REPORT SCOPE

This report delivers a comprehensive overview of the global Sirolimus API market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Sirolimus API. The Sirolimus API market size, estimates, and forecasts are provided in terms of output/shipments (Tons) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Sirolimus API market comprehensively. Regional market sizes by Purity, by Application, by Product Grade, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Sirolimus API manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Purity, by Application, and by region.

biaoTi CHAPTER OUTLINE

marn_i1

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Purity, by Application, by Product Grade, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.

marn_i1

Chapter 2: Provides a detailed analysis of the competitive landscape for Sirolimus API manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.

marn_i1

Chapter 3: Examines Sirolimus API production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.

marn_i1

Chapter 4: Analyzes Sirolimus API consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.

marn_i1

Chapter 5: Analyzes market segments by Purity, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.

marn_i1

Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.

marn_i1

Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.

marn_i1

Chapter 8: Reviews the industry value chain, including upstream and downstream segments.

marn_i1

Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.

marn_i1

Chapter 10: Summarizes the key findings and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Sirolimus API Market Overview

1.1 Product Definition

1.2 Sirolimus API by Purity

1.2.1 Global Sirolimus API Market Value Growth Rate Analysis by Purity: 2025 vs 2032

1.2.2 98%-99%

1.2.3 Above 99%

1.3 Sirolimus API by Product Grade

1.3.1 Global Sirolimus API Market Value Growth Rate Analysis by Product Grade: 2025 vs 2032

1.3.2 Pharmaceutical Grade

1.3.3 Cosmetic Grade

1.4 Sirolimus API by Customer Type

1.4.1 Global Sirolimus API Market Value Growth Rate Analysis by Customer Type: 2025 vs 2032

1.4.2 Pharmaceutical Companies

1.4.3 Medical Device Manufacturers

1.4.4 CDMO/Research Institutions

1.5 Sirolimus API by Application

1.5.1 Global Sirolimus API Market Value Growth Rate Analysis by Application: 2025 vs 2032

1.5.2 Tablets

1.5.3 Oral Solution

1.5.4 Gel

1.5.5 Others

1.6 Global Market Growth Prospects

1.6.1 Global Sirolimus API Production Value Estimates and Forecasts (2021–2032)

1.6.2 Global Sirolimus API Production Capacity Estimates and Forecasts (2021–2032)

1.6.3 Global Sirolimus API Production Estimates and Forecasts (2021–2032)

1.6.4 Global Sirolimus API Market Average Price Estimates and Forecasts (2021–2032)

1.7 Assumptions and Limitations

muLu

2 Market Competition by Manufacturers

2.1 Global Sirolimus API Production Market Share by Manufacturers (2021–2026)

2.2 Global Sirolimus API Production Value Market Share by Manufacturers (2021–2026)

2.3 Global Key Players of Sirolimus API, Industry Ranking, 2024 vs 2025

2.4 Global Sirolimus API Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.5 Global Sirolimus API Average Price by Manufacturers (2021–2026)

2.6 Global Key Manufacturers of Sirolimus API, Manufacturing Footprints and Headquarters

2.7 Global Key Manufacturers of Sirolimus API, Product Offerings and Applications

2.8 Global Key Manufacturers of Sirolimus API, Date of Entry into the Industry

2.9 Sirolimus API Market Competitive Situation and Trends

2.9.1 Sirolimus API Market Concentration Rate

2.9.2 Top 5 and Top 10 Global Sirolimus API Players Market Share by Revenue

2.10 Mergers & Acquisitions and Expansion

muLu

3 Sirolimus API Production by Region

3.1 Global Sirolimus API Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032

3.2 Global Sirolimus API Production Value by Region (2021–2032)

3.2.1 Global Sirolimus API Production Value by Region (2021–2026)

3.2.2 Global Forecasted Production Value of Sirolimus API by Region (2027–2032)

3.3 Global Sirolimus API Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032

3.4 Global Sirolimus API Production Volume by Region (2021–2032)

3.4.1 Global Sirolimus API Production by Region (2021–2026)

3.4.2 Global Forecasted Production of Sirolimus API by Region (2027–2032)

3.5 Global Sirolimus API Market Price Analysis by Region (2021–2032)

3.6 Global Sirolimus API Production, Value, and Year-over-Year Growth

3.6.1 North America Sirolimus API Production Value Estimates and Forecasts (2021–2032)

3.6.2 Europe Sirolimus API Production Value Estimates and Forecasts (2021–2032)

3.6.3 China Sirolimus API Production Value Estimates and Forecasts (2021–2032)

3.6.4 Japan Sirolimus API Production Value Estimates and Forecasts (2021–2032)

muLu

4 Sirolimus API Consumption by Region

4.1 Global Sirolimus API Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032

4.2 Global Sirolimus API Consumption by Region (2021–2032)

4.2.1 Global Sirolimus API Consumption by Region (2021–2026)

4.2.2 Global Sirolimus API Forecasted Consumption by Region (2027–2032)

4.3 North America

4.3.1 North America Sirolimus API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032

4.3.2 North America Sirolimus API Consumption by Country (2021–2032)

4.3.3 U.S.

4.3.4 Canada

4.4 Europe

4.4.1 Europe Sirolimus API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032

4.4.2 Europe Sirolimus API Consumption by Country (2021–2032)

4.4.3 Germany

4.4.4 France

4.4.5 U.K.

4.4.6 Italy

4.4.7 Russia

4.5 Asia Pacific

4.5.1 Asia Pacific Sirolimus API Consumption Growth Rate by Region: 2021 vs 2025 vs 2032

4.5.2 Asia Pacific Sirolimus API Consumption by Region (2021–2032)

4.5.3 China

4.5.4 Japan

4.5.5 South Korea

4.5.6 China Taiwan

4.5.7 Southeast Asia

4.5.8 India

4.6 Latin America, Middle East & Africa

4.6.1 Latin America, Middle East & Africa Sirolimus API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032

4.6.2 Latin America, Middle East & Africa Sirolimus API Consumption by Country (2021–2032)

4.6.3 Mexico

4.6.4 Brazil

4.6.5 Turkey

4.6.6 GCC Countries

muLu

5 Segment by Purity

5.1 Global Sirolimus API Production by Purity (2021–2032)

5.1.1 Global Sirolimus API Production by Purity (2021–2026)

5.1.2 Global Sirolimus API Production by Purity (2027–2032)

5.1.3 Global Sirolimus API Production Market Share by Purity (2021–2032)

5.2 Global Sirolimus API Production Value by Purity (2021–2032)

5.2.1 Global Sirolimus API Production Value by Purity (2021–2026)

5.2.2 Global Sirolimus API Production Value by Purity (2027–2032)

5.2.3 Global Sirolimus API Production Value Market Share by Purity (2021–2032)

5.3 Global Sirolimus API Price by Purity (2021–2032)

muLu

6 Segment by Application

6.1 Global Sirolimus API Production by Application (2021–2032)

6.1.1 Global Sirolimus API Production by Application (2021–2026)

6.1.2 Global Sirolimus API Production by Application (2027–2032)

6.1.3 Global Sirolimus API Production Market Share by Application (2021–2032)

6.2 Global Sirolimus API Production Value by Application (2021–2032)

6.2.1 Global Sirolimus API Production Value by Application (2021–2026)

6.2.2 Global Sirolimus API Production Value by Application (2027–2032)

6.2.3 Global Sirolimus API Production Value Market Share by Application (2021–2032)

6.3 Global Sirolimus API Price by Application (2021–2032)

muLu

7 Key Companies Profiled

7.1 Concord Biotech

7.1.1 Concord Biotech Sirolimus API Company Information

7.1.2 Concord Biotech Sirolimus API Product Portfolio

7.1.3 Concord Biotech Sirolimus API Production, Value, Price, and Gross Margin (2021–2026)

7.1.4 Concord Biotech Main Business and Markets Served

7.1.5 Concord Biotech Recent Developments/Updates

7.2 Curia Italy

7.2.1 Curia Italy Sirolimus API Company Information

7.2.2 Curia Italy Sirolimus API Product Portfolio

7.2.3 Curia Italy Sirolimus API Production, Value, Price, and Gross Margin (2021–2026)

7.2.4 Curia Italy Main Business and Markets Served

7.2.5 Curia Italy Recent Developments/Updates

7.3 Lonza Biologics Tuas Pte Ltd

7.3.1 Lonza Biologics Tuas Pte Ltd Sirolimus API Company Information

7.3.2 Lonza Biologics Tuas Pte Ltd Sirolimus API Product Portfolio

7.3.3 Lonza Biologics Tuas Pte Ltd Sirolimus API Production, Value, Price, and Gross Margin (2021–2026)

7.3.4 Lonza Biologics Tuas Pte Ltd Main Business and Markets Served

7.3.5 Lonza Biologics Tuas Pte Ltd Recent Developments/Updates

7.4 Apotex Pharmachem

7.4.1 Apotex Pharmachem Sirolimus API Company Information

7.4.2 Apotex Pharmachem Sirolimus API Product Portfolio

7.4.3 Apotex Pharmachem Sirolimus API Production, Value, Price, and Gross Margin (2021–2026)

7.4.4 Apotex Pharmachem Main Business and Markets Served

7.4.5 Apotex Pharmachem Recent Developments/Updates

7.5 Chunghwa Chemical Synthesis & Biotech

7.5.1 Chunghwa Chemical Synthesis & Biotech Sirolimus API Company Information

7.5.2 Chunghwa Chemical Synthesis & Biotech Sirolimus API Product Portfolio

7.5.3 Chunghwa Chemical Synthesis & Biotech Sirolimus API Production, Value, Price, and Gross Margin (2021–2026)

7.5.4 Chunghwa Chemical Synthesis & Biotech Main Business and Markets Served

7.5.5 Chunghwa Chemical Synthesis & Biotech Recent Developments/Updates

7.6 Hisun Pharmaceutical

7.6.1 Hisun Pharmaceutical Sirolimus API Company Information

7.6.2 Hisun Pharmaceutical Sirolimus API Product Portfolio

7.6.3 Hisun Pharmaceutical Sirolimus API Production, Value, Price, and Gross Margin (2021–2026)

7.6.4 Hisun Pharmaceutical Main Business and Markets Served

7.6.5 Hisun Pharmaceutical Recent Developments/Updates

7.7 Fujian Kerui Pharmaceutical

7.7.1 Fujian Kerui Pharmaceutical Sirolimus API Company Information

7.7.2 Fujian Kerui Pharmaceutical Sirolimus API Product Portfolio

7.7.3 Fujian Kerui Pharmaceutical Sirolimus API Production, Value, Price, and Gross Margin (2021–2026)

7.7.4 Fujian Kerui Pharmaceutical Main Business and Markets Served

7.7.5 Fujian Kerui Pharmaceutical Recent Developments/Updates

7.8 Lunan New Time Bio Tech

7.8.1 Lunan New Time Bio Tech Sirolimus API Company Information

7.8.2 Lunan New Time Bio Tech Sirolimus API Product Portfolio

7.8.3 Lunan New Time Bio Tech Sirolimus API Production, Value, Price, and Gross Margin (2021–2026)

7.8.4 Lunan New Time Bio Tech Main Business and Markets Served

7.8.5 Lunan New Time Bio Tech Recent Developments/Updates

7.9 BrightGene Bio-Medical Technology

7.9.1 BrightGene Bio-Medical Technology Sirolimus API Company Information

7.9.2 BrightGene Bio-Medical Technology Sirolimus API Product Portfolio

7.9.3 BrightGene Bio-Medical Technology Sirolimus API Production, Value, Price, and Gross Margin (2021–2026)

7.9.4 BrightGene Bio-Medical Technology Main Business and Markets Served

7.9.5 BrightGene Bio-Medical Technology Recent Developments/Updates

7.10 Hangzhou Zhongmei Huadong Pharmaceutical

7.10.1 Hangzhou Zhongmei Huadong Pharmaceutical Sirolimus API Company Information

7.10.2 Hangzhou Zhongmei Huadong Pharmaceutical Sirolimus API Product Portfolio

7.10.3 Hangzhou Zhongmei Huadong Pharmaceutical Sirolimus API Production, Value, Price, and Gross Margin (2021–2026)

7.10.4 Hangzhou Zhongmei Huadong Pharmaceutical Main Business and Markets Served

7.10.5 Hangzhou Zhongmei Huadong Pharmaceutical Recent Developments/Updates

7.11 Chongqing Daxin Pharmaceutical

7.11.1 Chongqing Daxin Pharmaceutical Sirolimus API Company Information

7.11.2 Chongqing Daxin Pharmaceutical Sirolimus API Product Portfolio

7.11.3 Chongqing Daxin Pharmaceutical Sirolimus API Production, Value, Price, and Gross Margin (2021–2026)

7.11.4 Chongqing Daxin Pharmaceutical Main Business and Markets Served

7.11.5 Chongqing Daxin Pharmaceutical Recent Developments/Updates

7.12 North China Pharmaceutical Huasheng

7.12.1 North China Pharmaceutical Huasheng Sirolimus API Company Information

7.12.2 North China Pharmaceutical Huasheng Sirolimus API Product Portfolio

7.12.3 North China Pharmaceutical Huasheng Sirolimus API Production, Value, Price, and Gross Margin (2021–2026)

7.12.4 North China Pharmaceutical Huasheng Main Business and Markets Served

7.12.5 North China Pharmaceutical Huasheng Recent Developments/Updates

7.13 Zhejiang Wild Wind Pharmaceutical

7.13.1 Zhejiang Wild Wind Pharmaceutical Sirolimus API Company Information

7.13.2 Zhejiang Wild Wind Pharmaceutical Sirolimus API Product Portfolio

7.13.3 Zhejiang Wild Wind Pharmaceutical Sirolimus API Production, Value, Price, and Gross Margin (2021–2026)

7.13.4 Zhejiang Wild Wind Pharmaceutical Main Business and Markets Served

7.13.5 Zhejiang Wild Wind Pharmaceutical Recent Developments/Updates

7.14 Yangzhou Lianao Biopharmaceutical

7.14.1 Yangzhou Lianao Biopharmaceutical Sirolimus API Company Information

7.14.2 Yangzhou Lianao Biopharmaceutical Sirolimus API Product Portfolio

7.14.3 Yangzhou Lianao Biopharmaceutical Sirolimus API Production, Value, Price, and Gross Margin (2021–2026)

7.14.4 Yangzhou Lianao Biopharmaceutical Main Business and Markets Served

7.14.5 Yangzhou Lianao Biopharmaceutical Recent Developments/Updates

muLu

8 Industry Chain and Sales Channels Analysis

8.1 Sirolimus API Industry Chain Analysis

8.2 Sirolimus API Raw Material Supply Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.3 Sirolimus API Production Modes and Processes

8.4 Sirolimus API Sales and Marketing

8.4.1 Sirolimus API Sales Channels

8.4.2 Sirolimus API Distributors

8.5 Sirolimus API Customer Analysis

muLu

9 Sirolimus API Market Dynamics

9.1 Sirolimus API Industry Trends

9.2 Sirolimus API Market Drivers

9.3 Sirolimus API Market Challenges

9.4 Sirolimus API Market Restraints

9.5 Impact of U.S. Tariffs

muLu

10 Research Findings and Conclusion

muLu

11 Methodology and Data Source

11.1 Methodology/Research Approach

11.1.1 Research Programs/Design

11.1.2 Market Size Estimation

11.1.3 Market Breakdown and Data Triangulation

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Author List

11.4 Disclaimer

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Global Sirolimus API Market Value by Purity (US$ Million), 2025 vs 2032
Table 2. Global Sirolimus API Market Value by Product Grade (US$ Million), 2025 vs 2032
Table 3. Global Sirolimus API Market Value by Customer Type (US$ Million), 2025 vs 2032
Table 4. Global Sirolimus API Market Value by Application (US$ Million), 2025 vs 2032
Table 5. Global Sirolimus API Production Capacity (Tons) by Manufacturers in 2025
Table 6. Global Sirolimus API Production by Manufacturers (Tons), 2021–2026
Table 7. Global Sirolimus API Production Market Share by Manufacturers (2021–2026)
Table 8. Global Sirolimus API Production Value by Manufacturers (US$ Million), 2021–2026
Table 9. Global Sirolimus API Production Value Share by Manufacturers (2021–2026)
Table 10. Global Key Players of Sirolimus API, Industry Ranking, 2024 vs 2025
Table 11. Classification of Companies by Tier (Tier 1, Tier 2, Tier 3), based on Sirolimus API Production Value, 2025
Table 12. Global Market Sirolimus API Average Price by Manufacturers (US$/kg), 2021–2026
Table 13. Global Key Manufacturers of Sirolimus API, Manufacturing Footprints and Headquarters
Table 14. Global Key Manufacturers of Sirolimus API, Product Offerings and Applications
Table 15. Global Key Manufacturers of Sirolimus API, Date of Entry into the Industry
Table 16. Global Sirolimus API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Mergers & Acquisitions and Expansion Plans
Table 18. Global Sirolimus API Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 19. Global Sirolimus API Production Value (US$ Million) by Region (2021–2026)
Table 20. Global Sirolimus API Production Value Market Share by Region (2021–2026)
Table 21. Global Sirolimus API Production Value (US$ Million) Forecast by Region (2027–2032)
Table 22. Global Sirolimus API Production Value Market Share Forecast by Region (2027–2032)
Table 23. Global Sirolimus API Production Comparison by Region: 2021 vs 2025 vs 2032 (Tons)
Table 24. Global Sirolimus API Production (Tons) by Region (2021–2026)
Table 25. Global Sirolimus API Production Market Share by Region (2021–2026)
Table 26. Global Sirolimus API Production (Tons) Forecast by Region (2027–2032)
Table 27. Global Sirolimus API Production Market Share Forecast by Region (2027–2032)
Table 28. Global Sirolimus API Market Average Price (US$/kg) by Region (2021–2026)
Table 29. Global Sirolimus API Market Average Price (US$/kg) by Region (2027–2032)
Table 30. Global Sirolimus API Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (Tons)
Table 31. Global Sirolimus API Consumption by Region (Tons), 2021–2026
Table 32. Global Sirolimus API Consumption Market Share by Region (2021–2026)
Table 33. Global Sirolimus API Forecasted Consumption by Region (Tons), 2027–2032
Table 34. Global Sirolimus API Forecasted Consumption Market Share by Region (2027–2032)
Table 35. North America Sirolimus API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (Tons)
Table 36. North America Sirolimus API Consumption by Country (Tons), 2021–2026
Table 37. North America Sirolimus API Consumption by Country (Tons), 2027–2032
Table 38. Europe Sirolimus API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (Tons)
Table 39. Europe Sirolimus API Consumption by Country (Tons), 2021–2026
Table 40. Europe Sirolimus API Consumption by Country (Tons), 2027–2032
Table 41. Asia Pacific Sirolimus API Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (Tons)
Table 42. Asia Pacific Sirolimus API Consumption by Region (Tons), 2021–2026
Table 43. Asia Pacific Sirolimus API Consumption by Region (Tons), 2027–2032
Table 44. Latin America, Middle East & Africa Sirolimus API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (Tons)
Table 45. Latin America, Middle East & Africa Sirolimus API Consumption by Country (Tons), 2021–2026
Table 46. Latin America, Middle East & Africa Sirolimus API Consumption by Country (Tons), 2027–2032
Table 47. Global Sirolimus API Production (Tons) by Purity (2021–2026)
Table 48. Global Sirolimus API Production (Tons) by Purity (2027–2032)
Table 49. Global Sirolimus API Production Market Share by Purity (2021–2026)
Table 50. Global Sirolimus API Production Market Share by Purity (2027–2032)
Table 51. Global Sirolimus API Production Value (US$ Million) by Purity (2021–2026)
Table 52. Global Sirolimus API Production Value (US$ Million) by Purity (2027–2032)
Table 53. Global Sirolimus API Production Value Market Share by Purity (2021–2026)
Table 54. Global Sirolimus API Production Value Market Share by Purity (2027–2032)
Table 55. Global Sirolimus API Price (US$/kg) by Purity (2021–2026)
Table 56. Global Sirolimus API Price (US$/kg) by Purity (2027–2032)
Table 57. Global Sirolimus API Production (Tons) by Application (2021–2026)
Table 58. Global Sirolimus API Production (Tons) by Application (2027–2032)
Table 59. Global Sirolimus API Production Market Share by Application (2021–2026)
Table 60. Global Sirolimus API Production Market Share by Application (2027–2032)
Table 61. Global Sirolimus API Production Value (US$ Million) by Application (2021–2026)
Table 62. Global Sirolimus API Production Value (US$ Million) by Application (2027–2032)
Table 63. Global Sirolimus API Production Value Market Share by Application (2021–2026)
Table 64. Global Sirolimus API Production Value Market Share by Application (2027–2032)
Table 65. Global Sirolimus API Price (US$/kg) by Application (2021–2026)
Table 66. Global Sirolimus API Price (US$/kg) by Application (2027–2032)
Table 67. Concord Biotech Sirolimus API Company Information
Table 68. Concord Biotech Sirolimus API Specification and Application
Table 69. Concord Biotech Sirolimus API Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
Table 70. Concord Biotech Main Business and Markets Served
Table 71. Concord Biotech Recent Developments/Updates
Table 72. Curia Italy Sirolimus API Company Information
Table 73. Curia Italy Sirolimus API Specification and Application
Table 74. Curia Italy Sirolimus API Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
Table 75. Curia Italy Main Business and Markets Served
Table 76. Curia Italy Recent Developments/Updates
Table 77. Lonza Biologics Tuas Pte Ltd Sirolimus API Company Information
Table 78. Lonza Biologics Tuas Pte Ltd Sirolimus API Specification and Application
Table 79. Lonza Biologics Tuas Pte Ltd Sirolimus API Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
Table 80. Lonza Biologics Tuas Pte Ltd Main Business and Markets Served
Table 81. Lonza Biologics Tuas Pte Ltd Recent Developments/Updates
Table 82. Apotex Pharmachem Sirolimus API Company Information
Table 83. Apotex Pharmachem Sirolimus API Specification and Application
Table 84. Apotex Pharmachem Sirolimus API Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
Table 85. Apotex Pharmachem Main Business and Markets Served
Table 86. Apotex Pharmachem Recent Developments/Updates
Table 87. Chunghwa Chemical Synthesis & Biotech Sirolimus API Company Information
Table 88. Chunghwa Chemical Synthesis & Biotech Sirolimus API Specification and Application
Table 89. Chunghwa Chemical Synthesis & Biotech Sirolimus API Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
Table 90. Chunghwa Chemical Synthesis & Biotech Main Business and Markets Served
Table 91. Chunghwa Chemical Synthesis & Biotech Recent Developments/Updates
Table 92. Hisun Pharmaceutical Sirolimus API Company Information
Table 93. Hisun Pharmaceutical Sirolimus API Specification and Application
Table 94. Hisun Pharmaceutical Sirolimus API Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
Table 95. Hisun Pharmaceutical Main Business and Markets Served
Table 96. Hisun Pharmaceutical Recent Developments/Updates
Table 97. Fujian Kerui Pharmaceutical Sirolimus API Company Information
Table 98. Fujian Kerui Pharmaceutical Sirolimus API Specification and Application
Table 99. Fujian Kerui Pharmaceutical Sirolimus API Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
Table 100. Fujian Kerui Pharmaceutical Main Business and Markets Served
Table 101. Fujian Kerui Pharmaceutical Recent Developments/Updates
Table 102. Lunan New Time Bio Tech Sirolimus API Company Information
Table 103. Lunan New Time Bio Tech Sirolimus API Specification and Application
Table 104. Lunan New Time Bio Tech Sirolimus API Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
Table 105. Lunan New Time Bio Tech Main Business and Markets Served
Table 106. Lunan New Time Bio Tech Recent Developments/Updates
Table 107. BrightGene Bio-Medical Technology Sirolimus API Company Information
Table 108. BrightGene Bio-Medical Technology Sirolimus API Specification and Application
Table 109. BrightGene Bio-Medical Technology Sirolimus API Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
Table 110. BrightGene Bio-Medical Technology Main Business and Markets Served
Table 111. BrightGene Bio-Medical Technology Recent Developments/Updates
Table 112. Hangzhou Zhongmei Huadong Pharmaceutical Sirolimus API Company Information
Table 113. Hangzhou Zhongmei Huadong Pharmaceutical Sirolimus API Specification and Application
Table 114. Hangzhou Zhongmei Huadong Pharmaceutical Sirolimus API Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
Table 115. Hangzhou Zhongmei Huadong Pharmaceutical Main Business and Markets Served
Table 116. Hangzhou Zhongmei Huadong Pharmaceutical Recent Developments/Updates
Table 117. Chongqing Daxin Pharmaceutical Sirolimus API Company Information
Table 118. Chongqing Daxin Pharmaceutical Sirolimus API Specification and Application
Table 119. Chongqing Daxin Pharmaceutical Sirolimus API Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
Table 120. Chongqing Daxin Pharmaceutical Main Business and Markets Served
Table 121. Chongqing Daxin Pharmaceutical Recent Developments/Updates
Table 122. North China Pharmaceutical Huasheng Sirolimus API Company Information
Table 123. North China Pharmaceutical Huasheng Sirolimus API Specification and Application
Table 124. North China Pharmaceutical Huasheng Sirolimus API Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
Table 125. North China Pharmaceutical Huasheng Main Business and Markets Served
Table 126. North China Pharmaceutical Huasheng Recent Developments/Updates
Table 127. Zhejiang Wild Wind Pharmaceutical Sirolimus API Company Information
Table 128. Zhejiang Wild Wind Pharmaceutical Sirolimus API Specification and Application
Table 129. Zhejiang Wild Wind Pharmaceutical Sirolimus API Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
Table 130. Zhejiang Wild Wind Pharmaceutical Main Business and Markets Served
Table 131. Zhejiang Wild Wind Pharmaceutical Recent Developments/Updates
Table 132. Yangzhou Lianao Biopharmaceutical Sirolimus API Company Information
Table 133. Yangzhou Lianao Biopharmaceutical Sirolimus API Specification and Application
Table 134. Yangzhou Lianao Biopharmaceutical Sirolimus API Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
Table 135. Yangzhou Lianao Biopharmaceutical Main Business and Markets Served
Table 136. Yangzhou Lianao Biopharmaceutical Recent Developments/Updates
Table 137. Key Raw Materials Lists
Table 138. Raw Materials Key Suppliers Lists
Table 139. Sirolimus API Distributors List
Table 140. Sirolimus API Customers List
Table 141. Sirolimus API Market Trends
Table 142. Sirolimus API Market Drivers
Table 143. Sirolimus API Market Challenges
Table 144. Sirolimus API Market Restraints
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
Table 148. Authors List of This Report
muLu

List of Figures

Figure 1. Product Picture of Sirolimus API
Figure 2. Global Sirolimus API Market Value by Purity (US$ Million), 2021–2032
Figure 3. Global Sirolimus API Market Share by Purity: 2025 vs 2032
Figure 4. 98%-99% Product Picture
Figure 5. Above 99% Product Picture
Figure 6. Global Sirolimus API Market Value by Product Grade (US$ Million), 2021–2032
Figure 7. Global Sirolimus API Market Share by Product Grade: 2025 vs 2032
Figure 8. Pharmaceutical Grade Product Picture
Figure 9. Cosmetic Grade Product Picture
Figure 10. Global Sirolimus API Market Value by Customer Type (US$ Million), 2021–2032
Figure 11. Global Sirolimus API Market Share by Customer Type: 2025 vs 2032
Figure 12. Pharmaceutical Companies Product Picture
Figure 13. Medical Device Manufacturers Product Picture
Figure 14. CDMO/Research Institutions Product Picture
Figure 15. Global Sirolimus API Market Value by Application (US$ Million), 2021–2032
Figure 16. Global Sirolimus API Market Share by Application: 2025 vs 2032
Figure 17. Tablets
Figure 18. Oral Solution
Figure 19. Gel
Figure 20. Others
Figure 21. Global Sirolimus API Production Value (US$ Million), 2021 vs 2025 vs 2032
Figure 22. Global Sirolimus API Production Value (US$ Million), 2021–2032
Figure 23. Global Sirolimus API Production Capacity (Tons), 2021–2032
Figure 24. Global Sirolimus API Production (Tons), 2021–2032
Figure 25. Global Sirolimus API Average Price (US$/kg), 2021–2032
Figure 26. Sirolimus API Report Years Considered
Figure 27. Sirolimus API Production Share by Manufacturers in 2025
Figure 28. Global Sirolimus API Production Value Share by Manufacturers (2025)
Figure 29. Sirolimus API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 30. Top 5 and Top 10 Global Players: Market Share by Sirolimus API Revenue in 2025
Figure 31. Global Sirolimus API Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 32. Global Sirolimus API Production Value Market Share by Region: 2021 vs 2025 vs 2032
Figure 33. Global Sirolimus API Production Comparison by Region: 2021 vs 2025 vs 2032 (Tons)
Figure 34. Global Sirolimus API Production Market Share by Region: 2021 vs 2025 vs 2032
Figure 35. North America Sirolimus API Production Value (US$ Million) Growth Rate (2021–2032)
Figure 36. Europe Sirolimus API Production Value (US$ Million) Growth Rate (2021–2032)
Figure 37. China Sirolimus API Production Value (US$ Million) Growth Rate (2021–2032)
Figure 38. Japan Sirolimus API Production Value (US$ Million) Growth Rate (2021–2032)
Figure 39. Global Sirolimus API Consumption by Region: 2021 vs 2025 vs 2032 (Tons)
Figure 40. Global Sirolimus API Consumption Market Share by Region: 2021 vs 2025 vs 2032
Figure 41. North America Sirolimus API Consumption and Growth Rate (Tons), 2021–2032
Figure 42. North America Sirolimus API Consumption Market Share by Country (2021–2032)
Figure 43. U.S. Sirolimus API Consumption and Growth Rate (Tons), 2021–2032
Figure 44. Canada Sirolimus API Consumption and Growth Rate (Tons), 2021–2032
Figure 45. Europe Sirolimus API Consumption and Growth Rate (Tons), 2021–2032
Figure 46. Europe Sirolimus API Consumption Market Share by Country (2021–2032)
Figure 47. Germany Sirolimus API Consumption and Growth Rate (Tons), 2021–2032
Figure 48. France Sirolimus API Consumption and Growth Rate (Tons), 2021–2032
Figure 49. U.K. Sirolimus API Consumption and Growth Rate (Tons), 2021–2032
Figure 50. Italy Sirolimus API Consumption and Growth Rate (Tons), 2021–2032
Figure 51. Russia Sirolimus API Consumption and Growth Rate (Tons), 2021–2032
Figure 52. Asia Pacific Sirolimus API Consumption and Growth Rate (Tons), 2021–2032
Figure 53. Asia Pacific Sirolimus API Consumption Market Share by Region (2021–2032)
Figure 54. China Sirolimus API Consumption and Growth Rate (Tons), 2021–2032
Figure 55. Japan Sirolimus API Consumption and Growth Rate (Tons), 2021–2032
Figure 56. South Korea Sirolimus API Consumption and Growth Rate (Tons), 2021–2032
Figure 57. China Taiwan Sirolimus API Consumption and Growth Rate (Tons), 2021–2032
Figure 58. Southeast Asia Sirolimus API Consumption and Growth Rate (Tons), 2021–2032
Figure 59. India Sirolimus API Consumption and Growth Rate (Tons), 2021–2032
Figure 60. Latin America, Middle East & Africa Sirolimus API Consumption and Growth Rate (Tons), 2021–2032
Figure 61. Latin America, Middle East & Africa Sirolimus API Consumption Market Share by Country (2021–2032)
Figure 62. Mexico Sirolimus API Consumption and Growth Rate (Tons), 2021–2032
Figure 63. Brazil Sirolimus API Consumption and Growth Rate (Tons), 2021–2032
Figure 64. Turkey Sirolimus API Consumption and Growth Rate (Tons), 2021–2032
Figure 65. GCC Countries Sirolimus API Consumption and Growth Rate (Tons), 2021–2032
Figure 66. Global Production Market Share of Sirolimus API by Purity (2021–2032)
Figure 67. Global Production Value Market Share of Sirolimus API by Purity (2021–2032)
Figure 68. Global Sirolimus API Price (US$/kg) by Purity (2021–2032)
Figure 69. Global Production Market Share of Sirolimus API by Application (2021–2032)
Figure 70. Global Production Value Market Share of Sirolimus API by Application (2021–2032)
Figure 71. Global Sirolimus API Price (US$/kg) by Application (2021–2032)
Figure 72. Sirolimus API Value Chain
Figure 73. Channels of Distribution (Direct Vs Distribution)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Sirolimus API market?zhanKai
The top companies in the global Sirolimus API market are Concord Biotech、Curia Italy、Lonza Biologics Tuas Pte Ltd.
Which region is expected to have the highest market share?shouQi
What is the annual compound growth rate of the global Sirolimus API market size from 2026 to 2032?shouQi
What was the global market size of Sirolimus API in 2026?shouQi
What was the global market size of Sirolimus API in 2032?shouQi
den_biaoTiZhungShi

Related Reports

Global Sirolimus API Market Research Report 2026

Industry: Chemical & Material

Published Date: 2026-08-23

Pages: 143 Pages

Report ld: 6502876

CHOOSE LICENSE TYPE
tip

USD 2900.00

tip

USD 4350.00

tip

USD 5800.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

English,Chinese

Offline

HITESH

English, Hindi

Online

TANG XIN

Japanese,English

Online

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Online

YUJIE TIAN

Chinese, English

Online

DAMON

Chinese, English

Online

General Email:

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

OVERVIEW

den_ic7

MARKET SEGMENTATION

den_ic7

REPORT SCOPE

den_ic7

CHAPTER OUTLINE

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now